These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 17228758)

  • 1. [Different outcome among eyes with proliferative diabetic retinopathy indicated for vitrectomy].
    Muramatsu M; Yokoi M; Muramatsu A; Saito W; Furudate N; Ohno S
    Nippon Ganka Gakkai Zasshi; 2006 Dec; 110(12):950-60. PubMed ID: 17228758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of vitrectomy without endotamponade in proliferative diabetic retinopathy with tractional retinal detachment.
    Tao Y; Jiang YR; Li XX; Gao L; Jonas JB
    Retina; 2010 Mar; 30(3):447-51. PubMed ID: 20216292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy.
    Ghasemi Falavarjani K; Modarres M; Hadavandkhani A; Karimi Moghaddam A
    Eye (Lond); 2015 Sep; 29(9):1199-203. PubMed ID: 26160528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The visual outcome of vitrectomy for advanced diabetic retinopathy.
    Fulcher T; Acheson RW
    Ir Med J; 1995; 88(1):26-7. PubMed ID: 7737838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vitrectomy and proliferative diabetic retinopathy. Apropos of 66 eyes].
    Bouchard O; Zech JC; Trepsat C
    J Fr Ophtalmol; 1997; 20(4):263-70. PubMed ID: 9181137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [One year outcomes of pars plana vitrectomy in proliferative diabetic retinopathy].
    Tadera M; Kawamura H; Fujikawa M; Kakinoki M; Sawada T; Saishin Y; Ohji M
    Nippon Ganka Gakkai Zasshi; 2014 Jun; 118(6):502-7. PubMed ID: 25016792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
    Ozone D; Hirano Y; Ueda J; Yasukawa T; Yoshida M; Ogura Y
    Ophthalmologica; 2011; 226(2):76-80. PubMed ID: 21613797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment.
    Altan T; Acar N; Kapran Z; Unver YB; Ozdogan S
    Retina; 2008 Oct; 28(9):1201-6. PubMed ID: 18728620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of vitreous surgery for proliferative diabetic retinopathy.
    Sima P; Zoran T
    Doc Ophthalmol; 1994; 87(3):223-32. PubMed ID: 7835192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus].
    Li X; Jiang Y; Ye C; Li C
    Zhonghua Yan Ke Za Zhi; 1999 Mar; 35(2):116-8. PubMed ID: 11835788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitrectomy for proliferative diabetic retinopathy with asteroid hyalosis.
    Ikeda T; Sawa H; Koizumi K; Yasuhara T; Kinoshita S; Tano Y
    Retina; 1998; 18(5):410-4. PubMed ID: 9801034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of membrane dissection and en bloc excision on the outcome of vitreous surgery in proliferative diabetic retinopathy].
    Li XX; Jiang YR; Yin H; Zhao MW
    Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):439-42. PubMed ID: 15454056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute onset of rubeosis iridis after diabetic vitrectomy can indicate peripheral traction retinal detachment.
    Bopp S; Lucke K; Laqua H
    Ger J Ophthalmol; 1992; 1(6):375-81. PubMed ID: 1283355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.
    Yan H; Cui J; Lu Y; Yu J; Chen S; Xu Y
    Curr Eye Res; 2010 Apr; 35(4):308-13. PubMed ID: 20373898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. En bloc perfluorodissection for tractional retinal detachment in proliferative diabetic retinopathy.
    Arevalo JF
    Ophthalmology; 2008 Jun; 115(6):e21-5. PubMed ID: 18423870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pars plana vitrectomy, phacoemulsification and intraocular lens implantation for the management of cataract and proliferative diabetic retinopathy: comparison of a combined versus two-step surgical approach].
    Rivas-Aguiño P; García-Amaris RA; Berrocal MH; Sánchez JG; Rivas A; Arévalo JF
    Arch Soc Esp Oftalmol; 2009 Jan; 84(1):31-8. PubMed ID: 19173136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.
    Lee DY; Jeong HS; Sohn HJ; Nam DH
    Retina; 2011 Oct; 31(9):1753-8. PubMed ID: 21555968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
    Balakrishnan D; Jain B; Nayaka A; Rani PK; Mukundaprasad V; Jalali S
    Semin Ophthalmol; 2017; 32(4):488-491. PubMed ID: 27128601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitrectomy Due to Vitreous Hemorrhage and Tractional Retinal Detachment Secondary to Eales' Disease.
    Ersöz MG; Hocaoğlu M; Sayman Muslubaş IB; Arf S; Karaçorlu M
    Turk J Ophthalmol; 2021 Apr; 51(2):102-106. PubMed ID: 33951898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.
    Oshima Y; Shima C; Wakabayashi T; Kusaka S; Shiraga F; Ohji M; Tano Y
    Ophthalmology; 2009 May; 116(5):927-38. PubMed ID: 19269033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.